drugset / Trial / NCT04845490

Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy

NCT04845490

RandomizedParallel-groupSingle-blindTreatment

Summary

This study is a prospective, randomized, comparative clinical trial conducted by Wuhan Union Hospital and aim to compare the therapeutic effects of Mitomycin and Lobaplatin in the treatment of advanced colorectal cancer patients with radical surgery combined with hyperthermic intraperitoneal chemotherapy

Timeline

Start
2022-09-01
Primary completion
2023-09-01
Completion
2026-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lobaplatin Small molecule 50 mg/m2 Other
Subject Mitomycin C Other / unclassified 30 mg/m2 Other